ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
67 hedge funds and large institutions have $30.5M invested in Zynerba Pharmaceuticals, Inc in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
60% less capital invested
Capital invested by funds: $77M → $30.5M (-$46.5M)
Holders
67
Holding in Top 10
–
Calls
$8.36M
Puts
$3.12M
Top Buyers
| 1 | +$1.67M | |
| 2 | +$1.32M | |
| 3 | +$1.12M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$908K |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$542K |
Top Sellers
| 1 | -$7.78M | |
| 2 | -$6.66M | |
| 3 | -$3.26M | |
| 4 |
Citigroup
New York
|
-$1.81M |
| 5 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
-$1.53M |